Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence.

Front Endocrinol (Lausanne) · 2021 · PMC8688740 · PMID 34950104

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the preclinical evidence obtained from mouse models was promising, clinical evaluation of thiazolidinediones in patients with NASH or NAFLD produced variable outcomes or did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.